These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9363739)

  • 1. Priming of neutrophils after elective percutaneous transluminal coronary angioplasty is unrelated to accompanying brief myocardial ischemia.
    Giannitsis E; Tettenborn I; Schmücker G; Mitusch R; Wiegand U; Potratz J; Sheikhzadeh A; Stierle U
    Int J Cardiol; 1997 Oct; 61(3):229-37. PubMed ID: 9363739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac release of chemoattractants after ischaemia induced by coronary balloon angioplasty.
    Neumann FJ; Richardt G; Schneider M; Ott I; Haupt HM; Tillmanns H; Schömig A; Rauch B
    Br Heart J; 1993 Jul; 70(1):27-34. PubMed ID: 8037995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of short-term myocardial ischemia on the expression of adhesion molecules and the oxidative burst of coronary sinus blood neutrophils.
    Baj Z; Kowalski J; Kantorski J; Pokoca L; Kośmider M; Pawlicki L; Tchórzewski H
    Atherosclerosis; 1994 Apr; 106(2):159-68. PubMed ID: 7914725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical applications of coronary sinus retroperfusion during high risk percutaneous transluminal coronary angioplasty.
    Incorvati RL; Tauberg SG; Pecora MJ; Macherey RS; Krucoff MW; Dianzumba SB; Donohue BC
    J Am Coll Cardiol; 1993 Jul; 22(1):127-34. PubMed ID: 8509532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for priming and activation of neutrophils early after coronary angioplasty.
    Steg PG; Pasquier C; Huu TP; Chollet-Martin S; Juliard JM; Himbert D; Pocidalo MA; Gourgon R; Hakim J
    Eur J Med; 1993 Jan; 2(1):6-10. PubMed ID: 8258010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma mediated neutrophil stimulation during coronary angioplasty: autocrine effect of platelet activating factor.
    Siminiak T; O'Gorman DJ; Shahi M; Hackett D; Sheridan DJ
    Br Heart J; 1995 Dec; 74(6):625-30. PubMed ID: 8541167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of thromboxane production and complement activation during myocardial ischemia in patients with angina pectoris.
    Montalescot G; Drobinski G; Maclouf J; Maillet F; Salloum J; Ankri A; Kazatchkine M; Eugène L; Thomas D; Grosgogeat Y
    Circulation; 1991 Nov; 84(5):2054-62. PubMed ID: 1934381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble L-selectin and neutrophil derived oxidative stress after pacing induced myocardial ischemia in chronic stable coronary artery disease.
    Giannitsis E; Tettenborn I; Wiegand U; Stierle U; Katus HA
    Pacing Clin Electrophysiol; 2000 Mar; 23(3):309-14. PubMed ID: 10750129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil-derived oxidative stress after myocardial ischemia induced by incremental atrial pacing.
    Giannitsis E; Tettenborn I; Wiegand U; Potratz J; Sheikhzadeh A; Stierle U
    Pacing Clin Electrophysiol; 1998 Jan; 21(1 Pt 2):157-62. PubMed ID: 9474664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty (PTCA) by intracoronary dipyridamole: hemodynamic, contractile and dynamic ventricular consequences].
    Strauer BE; Heidland UE; Heintzen MP; Schwartzkopff B
    Z Kardiol; 1995 Nov; 84(11):898-910. PubMed ID: 8571641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features.
    Deutsch E; Berger M; Kussmaul WG; Hirshfeld JW; Herrmann HC; Laskey WK
    Circulation; 1990 Dec; 82(6):2044-51. PubMed ID: 2242528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated coronary artery occlusions during routine balloon angioplasty do not induce myocardial preconditioning in humans.
    Dupouy P; Geschwind H; Pelle G; Aptecar E; Hittinger L; El Ghalid A; Dubois-Randé JL
    J Am Coll Cardiol; 1996 May; 27(6):1374-80. PubMed ID: 8626946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of myocardial ischemia during percutaneous transluminal coronary angioplasty in patients with significant narrowing of a single coronary artery and stable or unstable angina pectoris.
    Tomai F; Crea F; Gaspardone A; Versaci F; De Paulis R; Penta de Peppo A; Bassano C; Chiariello L; Gioffrè PA
    Am J Cardiol; 1994 Dec; 74(11):1089-94. PubMed ID: 7977064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with the release of cardiac troponin T following percutaneous transluminal coronary angioplasty.
    Abbas SA; Glazier JJ; Wu AH; Dupont C; Green SF; Pearsall LA; Waters DD; McKay RG
    Clin Cardiol; 1996 Oct; 19(10):782-6. PubMed ID: 8896910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ST-segment deviation to scintigraphically quantified myocardial ischemia during acute coronary occlusion induced by percutaneous transluminal coronary angioplasty.
    Persson E; Pettersson J; Ringborn M; Sörnmo L; Warren SG; Wagner GS; Maynard C; Pahlm O
    Am J Cardiol; 2006 Feb; 97(3):295-300. PubMed ID: 16442384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elective coronary angioplasty with 60 s balloon inflation does not cause peroxidative injury.
    Cedro K; Marczak E; Czerwosz L; Herbaczynska-Cedro K; Ruzyłło W
    Eur J Clin Invest; 2002 Mar; 32(3):148-52. PubMed ID: 11895464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac release and kinetics of endothelin after uncomplicated percutaneous transluminal coronary angioplasty.
    Krüger D; Giannitsis E; Sheikhzadeh A; Stierle U
    Am J Cardiol; 1998 Jun; 81(12):1421-6. PubMed ID: 9645891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of atrial natriuretic peptide in relation to metabolic changes during myocardial ischaemia induced by coronary angioplasty.
    Uusimaa PA; Ikäheimo MJ; Ruskoaho H; Airaksinen KE; Huikuri HV; Linnaluoto MK; Takkunen JT; Peuhkurinen KJ
    Eur Heart J; 1993 May; 14(5):682-6. PubMed ID: 8508861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective analysis of possible myocardial damage or hemolysis occurring as a result of prolonged autoperfusion angioplasty in humans.
    Muhlestein JB; Quigley PJ; Ohman EM; Bauman RP; Sketch MH; Tcheng JE; Davidson CJ; Peter RH; Behar VS; Krucoff MW
    J Am Coll Cardiol; 1992 Sep; 20(3):594-8. PubMed ID: 1512338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and angiographic outcomes after coronary artery stenting for acute or threatened closure after percutaneous transluminal coronary angioplasty. Initial results with a balloon-expandable, stainless steel design.
    Hearn JA; King SB; Douglas JS; Carlin SF; Lembo NJ; Ghazzal ZM
    Circulation; 1993 Nov; 88(5 Pt 1):2086-96. PubMed ID: 8222102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.